Rebecca,
51-year-old White womana
Rebecca wants to be a part of her children’s lives as long as she can. Consider how your own goals of meeting important milestones could shape treatment conversations with your care team
Background
- Single mother of 2 who also works as lawyer in a busy law firm
MM diagnosis
- Began experiencing severe fatigue. After several months of doctors’ visits, she was diagnosed with MM
Current health, MM status, and concerns
- Relapsed MM with fatigue and mild anemia
- No other health issues unrelated to MM
Concerned about being here to experience important milestones in her children’s lives
Rebecca’s Treatment History
- 68 MOFirst treatment: As she was otherwise in good health, she joined a clinical trial of a 4-drug combination regimen followed by stem cell transplant. Rebecca responded well. As part of the trial, she continued taking 2 of the drugs (anti-CD38 mAb and IMiD) as maintenance therapy to keep her MM under control
- Now: Relapse
Treatment Goals and Considerations
- Her doctor wants to use the therapy that is most effective and prevents the myeloma from getting worse
- Rebecca agrees and prefers a treatment that
- ‒Prevents the myeloma from getting worse
- ‒Will give her the chance of living longer to reach important milestones in her children’s lives
aThis patient profile is hypothetical and represents a type of patient typically seen in clinical practice.
CD, cluster of differentiation; IMiD, immunomodulatory drug; mAb, monoclonal antibody; MO, months; MM, multiple myeloma.